The US Food and Drug Administration (FDA) has granted priority review to AstraZeneca's supplemental biologics licence ...
Various ‘push-and-pull’ mechanisms have been tried to attract pharmaceutical companies into medical innovation for public ...
AstraZeneca's Imfinzi gains FDA Priority Review for bladder cancer. Key trial data shows improved survival and progression ...
The Food and Drug Administration (FDA) has granted Priority Review to durvalumab for the treatment of adults with muscle-invasive bladder cancer (MIBC). The coprimary endpoints were pathological ...
If approved, durvalumab will be the first and only perioperative immunotherapy regimen available for the treatment of ...
Ministers have been told to stop spending that does not contribute to the government's priorities, as Chancellor Rachel ...
The Priority Current has spent years as the flagship electric bike produced by Manhattan-based Priority Bicycles. Now the ...
December 06, 2024--(BUSINESS WIRE)--AstraZeneca’s supplemental Biologics License Application (sBLA) for IMFINZI ® (durvalumab) has been accepted and granted Priority Review in the US for the ...
Going out to eat? See which Marion County restaurants were rated best by inspectors, and which failed the test.